Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Teneligliptin(MP-513) vs. Placebo in Patient With Metformin Monotherapy (T2DM)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Handok Pharmaceuticals Co., Ltd.
ClinicalTrials.gov Identifier:
NCT01805830
First received: December 26, 2012
Last updated: October 5, 2015
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2013
  Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)